{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360021390765826048.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1038/s41698-023-00486-6"}},{"identifier":{"@type":"URI","@value":"https://www.nature.com/articles/s41698-023-00486-6.pdf"}},{"identifier":{"@type":"URI","@value":"https://www.nature.com/articles/s41698-023-00486-6"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"SHP2 inhibitors maintain TGFβ signalling through SMURF2 inhibition"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:title>Abstract</jats:title><jats:p>Despite the promising antitumor activity of SHP2 inhibitors in RAS-dependent tumours, overall responses have been limited by their narrow therapeutic window. Like with all MAPK pathway inhibitors, this is likely the result of compensatory pathway activation mechanisms. However, the underlying mechanisms of resistance to SHP2 inhibition remain unknown. The E3 ligase SMURF2 limits TGFβ activity by ubiquitinating and targeting the TGFβ receptor for proteosome degradation. Using a functional RNAi screen targeting all known phosphatases, we identify that the tyrosine phosphatase SHP2 is a critical regulator of TGFβ activity. Specifically, SHP2 dephosphorylates two key residues on SMURF2, resulting in activation of the enzyme. Conversely, SHP2 depletion maintains SMURF2 in an inactive state, resulting in the maintenance of TGFβ activity. Furthermore, we demonstrate that depleting SHP2 has significant implications on TGFβ-mediated migration, senescence, and cell survival. These effects can be overcome through the use of TGFβ-targeted therapies. Consequently, our findings provide a rationale for combining SHP2 and TGFβ inhibitors to enhance tumour responses leading to improved patient outcomes.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380021390765826056","@type":"Researcher","foaf:name":[{"@value":"Xianning Lai"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765825921","@type":"Researcher","foaf:name":[{"@value":"Sarah Kit Leng Lui"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765826087","@type":"Researcher","foaf:name":[{"@value":"Hiu Yan Lam"}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326231154560","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"30833842"},{"@type":"NRID","@value":"1000030833842"}],"foaf:name":[{"@value":"Yuta Adachi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765826048","@type":"Researcher","foaf:name":[{"@value":"Wen Jing Sim"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765825924","@type":"Researcher","foaf:name":[{"@value":"Natali Vasilevski"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765826071","@type":"Researcher","foaf:name":[{"@value":"Nicola J. Armstrong"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765826086","@type":"Researcher","foaf:name":[{"@value":"Stephanie Claire Bridgeman"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765825940","@type":"Researcher","foaf:name":[{"@value":"Nathan Michael Main"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765826078","@type":"Researcher","foaf:name":[{"@value":"Tuan Zea Tan"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765826070","@type":"Researcher","foaf:name":[{"@value":"Janina E. E. Tirnitz-Parker"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765826063","@type":"Researcher","foaf:name":[{"@value":"Jean Paul Thiery"}]},{"@id":"https://cir.nii.ac.jp/crid/1420282801182094208","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"00645145"},{"@type":"NRID","@value":"1000000645145"},{"@type":"NRID","@value":"9000414805062"},{"@type":"NRID","@value":"9000004684844"},{"@type":"NRID","@value":"9000016571090"},{"@type":"NRID","@value":"9000356539192"},{"@type":"NRID","@value":"9000014162392"},{"@type":"NRID","@value":"9000327084520"},{"@type":"NRID","@value":"9000360554261"},{"@type":"NRID","@value":"9000242351363"},{"@type":"NRID","@value":"9000403305311"},{"@type":"NRID","@value":"9000331452481"},{"@type":"NRID","@value":"9000331452334"},{"@type":"NRID","@value":"9000344129019"},{"@type":"NRID","@value":"9000331452329"},{"@type":"NRID","@value":"9000243837850"},{"@type":"NRID","@value":"9000259818725"},{"@type":"NRID","@value":"9000279640949"},{"@type":"NRID","@value":"9000361685934"},{"@type":"NRID","@value":"9000296684033"},{"@type":"NRID","@value":"9000404145543"},{"@type":"NRID","@value":"9000390406316"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/accri-dmt"}],"foaf:name":[{"@value":"Hiromichi Ebi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765826088","@type":"Researcher","foaf:name":[{"@value":"Alan Prem Kumar"}]},{"@id":"https://cir.nii.ac.jp/crid/1380021390765826054","@type":"Researcher","foaf:name":[{"@value":"Pieter Johan Adam Eichhorn"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"2397768X"}],"prism:publicationName":[{"@value":"npj Precision Oncology"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2023-12-15","prism:volume":"7","prism:number":"1"},"reviewed":"false","dc:rights":["https://creativecommons.org/licenses/by/4.0","https://creativecommons.org/licenses/by/4.0"],"url":[{"@id":"https://www.nature.com/articles/s41698-023-00486-6.pdf"},{"@id":"https://www.nature.com/articles/s41698-023-00486-6"}],"createdAt":"2023-12-15","modifiedAt":"2023-12-15","project":[{"@id":"https://cir.nii.ac.jp/crid/1040574181134185472","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"22K19473"},{"@type":"JGN","@value":"JP22K19473"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K19473/"}],"notation":[{"@language":"ja","@value":"分子標的治療薬耐性におけるoncometaboliteの役割の解明"},{"@language":"en","@value":"Elucidation of the role of oncometabolite in the resistance mechanism of molecular targeted therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1040577277053625600","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23K14639"},{"@type":"JGN","@value":"JP23K14639"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K14639/"}],"notation":[{"@language":"ja","@value":"KRASG12C阻害薬により誘導されるadaptive resistanceの解明"},{"@language":"en","@value":"Determine mechanism of resistance to KRAS G12C inhibitors"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360009142907544832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-β family"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144831942016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Nuclear Factor I-C Links Platelet-Derived Growth Factor and Transforming Growth Factor β1 Signaling to Skin Wound Healing Progression"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145007208064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145270767488","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021393300572032","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"SHP2 regulates intramembranous ossification by modifying the TGFβ and BMP2 signaling pathway"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021393300972672","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"[75] Assay of transforming activity of tumor virus DNA"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283692365664640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710935782272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292617906665728","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Molecular Signatures Database Hallmark Gene Set Collection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619058259840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619071816576","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619552093952","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Structural Basis for the Versatile Interactions of Smad7 with Regulator WW Domains in TGF-β Pathways"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294645719837696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TGF-β: An emerging player in drug resistance"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302867624477056","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The roles of ubiquitin modifying enzymes in neoplastic disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302867624985216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302870126622080","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TGF-β, EMT, and resistance to anti-cancer treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302871317532160","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302871317717888","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302871496172288","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The TGFß pathway as a therapeutic target in cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302871496821120","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093633843200","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093723877376","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094077210496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094252972160","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Specificity, versatility, and control of TGF-β family signaling"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095294608384","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095499193216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095690990464","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Germ-line and somatic PTPN11 mutations in human disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095771895424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580237193824512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Tumor Cell Escape from Therapy-Induced Senescence as a Model of Disease Recurrence after Dormancy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857594985890432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Non-genetic mechanisms of therapeutic resistance in cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861711803887232","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046174879488","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TGFβ signalling in context"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520921390080","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Src family kinase–Shp2 axis controls RUNX1 activity in megakaryocyte and T-lymphocyte differentiation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418521256053760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The great escape: tumour cell plasticity in resistance to targeted therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995312426624","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Regulation of Smurf2 Ubiquitin Ligase Activity by Anchoring the E2 to the HECT Domain"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469122766336","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Autoinhibition of the HECT-Type Ubiquitin Ligase Smurf2 through Its C2 Domain"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469522013696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470089625472","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470300007040","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Escaping from the TGF  anti-proliferative control"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943994512512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TGFβ biology in cancer progression and immunotherapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419604418816","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TGFβ in Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420335882368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TGF-β SIGNAL TRANSDUCTION"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370444749952","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Phenotype plasticity as enabler of melanoma progression and therapy resistance"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370879516416","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Identification of Novel TGF-β/Smad Gene Targets in Dermal Fibroblasts using a Combined cDNA Microarray/Promoter Transactivation Approach"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843274592896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A view on drug resistance in cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845484060288","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845788124288","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"c-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320288875776","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"<scp>USP</scp>\n                    26 regulates\n                    <scp>TGF</scp>\n                    ‐β signaling by deubiquitinating and stabilizing\n                    <scp>SMAD</scp>\n                    7"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670321130431488","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795472948224","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Immunoregulation by members of the TGFβ superfamily"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795784194048","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269132192512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ectopic TGFβ1 Expression in the Secretory Mammary Epithelium Induces Early Senescence of the Epithelial Stem Cell Population"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270390667264","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1038/s41698-023-00486-6"},{"@type":"KAKEN","@value":"PRODUCT-24817728"},{"@type":"KAKEN","@value":"PRODUCT-24776447"}]}